A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Dabigatran Impurity 15 - Request Quote

Picture of Dabigatran Impurity 15

Dabigatran Impurity 15

SZ CAT No:SZ-D012038
CAS No
NA
Mol.F.
C36H41N3O5
Mol.Wt.
595.7
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Dabigatran Impurity 15 is chemically Ethyl 3-(2-(((4-(heptanoylcarbamoyl)phenyl)amino)methyl)-N-phenyl-1H-indene-6-carboxamido)propanoate. Dabigatran Impurity 15 is supplied with detailed characterization data compliant with regulatory guideline. Dabigatran Impurity 15 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabigatran.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Dabigatran Impurity 15

Purchase Dabigatran Impurity 15

Dabigatran Impurity 15 suppliers

Dabigatran Impurity 15 manufacturers

Dabigatran Impurity 15 price

Order Dabigatran Impurity 15

Enquire Dabigatran Impurity 15

Dabigatran Impurity 15 cost

Dabigatran Impurity 15 Supplier

Dabigatran Impurity 15 Distributor

Dabigatran Impurity 15 for Method Validation

Dabigatran Reference Standard

Dabigatran Impurity 15 for ANDA Filing

Dabigatran Impurity 15 for Forced Degradation Studies

Dabigatran Impurity 15 Identification Standards

Dabigatran Impurity 15 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,